According to Suven Life Sciences latest financial reports the cash on hand of SUVEN is $9.93M, an increase of 65.28% to 2022. At the end of 2022 company had $6.01M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $9.93M | 65.28% |
2022 | $6.01M | 8.81% |
2021 | $5.52M | 214.79% |
2020 | $1.75M | -93.94% |
2019 | $28.95M | - |